Author:
Sikirica Vanja,Findling Robert L.,Signorovitch James,Erder M. Haim,Dammerman Ryan,Hodgkins Paul,Lu Mei,Xie Jipan,Wu Eric Q.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology
Reference23 articles.
1. American Psychiatric Association. Attention-deficit and disruptive behavior disorders. Diagnostic and statistical manual of mental disorders, 4th ed, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association, 2000, p. 85–93.
2. Wolraich M, Brown L, Brown RT, et al. Implementing the key action statements: an algorithm and explanation for process of care for the evaluation, diagnosis, treatment, and monitoring of ADHD in children and adolescents. Pediatrics. 2011;128(5, supplemental information):SI1–21.
3. Wilens TE, Spencer TJ. The stimulants revisited. Child Adolesc Psychiatr Clin N Am. 2009;9(3):573–603 (viii).
4. STRATTERA® (atomoxetine hydrochloride) capsules for oral use [package insert]. Indianapolis: Eli Lilly and Company; 2011.
5. INTUNIV® (guanfacine) extended-release tablets [package insert]. Wayne: Shire Pharmaceuticals LLC. 2013.
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献